OSL:NAVA • NO0010205966
The current stock price of NAVA.OL is 21.3 NOK. In the past month the price decreased by -1.84%. In the past year, price decreased by -0.47%.
ChartMill assigns a fundamental rating of 2 / 10 to NAVA.OL. NAVA.OL has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months NAVA.OL reported a non-GAAP Earnings per Share(EPS) of -2.21. The EPS decreased by -290.46% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.53% | ||
| ROE | -18.8% | ||
| Debt/Equity | 1.34 |
7 analysts have analysed NAVA.OL and the average price target is 36.72 NOK. This implies a price increase of 72.39% is expected in the next year compared to the current price of 21.3.
For the next year, analysts expect an EPS growth of -144.15% and a revenue growth 10.54% for NAVA.OL
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SNW | SANOFI | 9.26 | 189.068B | ||
| SAN | SANOFI | 9.27 | 188.706B | ||
| 1SAN | SANOFI | 9.24 | 188.634B | ||
| UNC | UCB SA | 27.93 | 55.863B | ||
| MRK | MERCK KGAA | 14.75 | 55.217B | ||
| UCB | UCB SA | 27.69 | 55.144B | ||
| BAYN | BAYER AG-REG | 9.01 | 48.448B | ||
| 1BAYN | BAYER AG-REG | 9.42 | 45.191B | ||
| IPN | IPSEN | 13.83 | 13.041B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 10.905B |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Oslo Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo and currently employs 42 full-time employees. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
NAVAMEDIC
Henrik Ibsens gate 100
Oslo OSLO NO
Employees: 45
Phone: 4767112540
Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo and currently employs 42 full-time employees. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
The current stock price of NAVA.OL is 21.3 NOK. The price decreased by -0.93% in the last trading session.
NAVA.OL does not pay a dividend.
NAVA.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
NAVAMEDIC (NAVA.OL) currently has 45 employees.
NAVAMEDIC (NAVA.OL) has a market capitalization of 510.77M NOK. This makes NAVA.OL a Small Cap stock.